Expert Interview
Discussing the potential of Biogen's BIIB080 and the results from the Phase 1b study of BIIB080 presented at the CTAD conference.
Ticker(s): BIIBInstitution: UTSA
- Distinguished as one of the top Alzheimer’s disease researchers with over 1,000 publications, one of the top 100 most-cited scientists in neuroscience and behavior, and one of the top 25 scientists in free radical research.
- can discuss the role of tau in disease pathology for Alzheimer's
- Research is primarily focused on how Alzheimer’s disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of increased oxygen radicals along with routes to provide more effective treatment.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
